What can we learn from the public’s understanding of drug information and safety? A population survey

Salgueiro, Esther; Gurruchaga, Cristina; Jimeno, Francisco J.; Martínez-Múgica, Cristina; Arias, Luis H. Martín; Manso, Gloria

doi:10.1111/ijpp.12458

Cited by 8 publications

(8 citation statements)

References 28 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The majority (43.1%) of participants reported that they always read the PIL which aligns with the findings of several studies from other countries [20,26,27]. A study in Spain mentioned that 61.4% of participants always read the PIL [20].…”

Section: Discussionsupporting

confidence: 87%

“…Moreover, a dedicated drug information service is available in healthcare settings of the Dammam region [23]. The score indicated adequate knowledge about medication use which was in line with the results reported by Salgueiro et al [20]. The score suggests good knowledge about medications among patients who were above 45, employed and married.…”

Section: Discussionsupporting

confidence: 85%

“…A questionnaire was adopted from the available literature and was further developed and validated [19,20]. The final version consisted of close ended questions covering the demographic information, the use of medications, reading and understanding the PIL, and the perception of drug safety.…”

Section: Questionnaire Development and Validationmentioning

confidence: 99%

See 2 more Smart Citations

Public Awareness about Medicine Information, Safety, and Adverse Drug Reaction (ADR) Reporting in Dammam, Saudi Arabia

et al. 2020

View full text Add to dashboard Cite

This study aimed to assess public knowledge about medicine information, safety, and adverse drug reaction reporting (ADR) in Dammam, Saudi Arabia. A cross sectional study was conducted using purposive stratified sampling in different settings of Dammam city for three months (January–March 2020). The target population was identified as consumers who had used the medicines in the last 3 months. The questionnaire was adopted from the literature and was validated. Content and face validities were established, and reliability was assessed. The study was approved by the concerned ethics committee. A total of 915 participants returned completed questionnaires. A total of 54.4% participants aged between 18 and 30 years, 65.8% were females and 53.1% had obtained bachelor level education. The mean score for knowledge of medicines (K1) was 5.46 ± 1.07. The mean score for knowledge regarding medication safety (K2) was 5.94 ± 1.73. The mean score for tendency to report a suspected ADR (T1) was 3.43 ± 1.57. Gender was a determinant of knowledge regarding medication safety (K2) (p < 0.01) and ADR reporting tendency (T1) (p < 0.01). The marital status of patients was a determinant for both knowledge of medicines (K1) (p < 0.01) and, knowledge regarding medication safety (K2) (p < 0.01). The results of this study highlighted that although the scores for knowledge of medicines, and tendency to report ADR were better, the score for knowledge regarding medication safety was unsatisfactory.

show abstract

Section: Discussionsupporting

confidence: 87%

Section: Discussionsupporting

confidence: 85%

See 1 more Smart Citation

Public Awareness about Medicine Information, Safety, and Adverse Drug Reaction (ADR) Reporting in Dammam, Saudi Arabia

et al. 2020

View full text Add to dashboard Cite

show abstract

“…Currently the black triangle and the accompanying statement are only present in the SmPC and PL. Previous research suggest that many patients find PLs hard to comprehend and have difficulties in finding the information they are looking for [21][22][23]. Many patients do not either read the PL [21][22][23].…”

Section: Discussionmentioning

confidence: 99%

“…Previous research suggest that many patients find PLs hard to comprehend and have difficulties in finding the information they are looking for [21][22][23]. Many patients do not either read the PL [21][22][23]. Adding the additional monitoring information also to outer packaging might help in raising awareness especially among the public.…”

Section: Discussionmentioning

confidence: 99%

Regulation Awareness and Experience of Additional Monitoring among Healthcare Professionals in Finland

Sandberg

Ehlers

Torvinen³

et al. 2021

Healthcare

View full text Add to dashboard Cite

Background: Challenges in post-marketing adverse event reporting are generally recognized. To enhance reporting, the concept of additional monitoring was introduced in 2012. Additional monitoring aims to enhance reporting of adverse events (AE) for medicines for which the clinical evidence base is less well developed. Purpose: The purpose was to get a deeper understanding of the underlying reasons why additional monitoring has not increased AE reporting as much as initially hoped. We examined how healthcare professionals (HCPs) in Finland perceive additional monitoring, why they do or do not report AEs more readily for these medicines and how they interact with patients treated with additionally monitored medicines. Methods: An anonymous, open questionnaire was developed and made available online at the e-form portal of University of Helsinki. Physicians, nurses, and pharmacists were invited to complete the questionnaire via their respective trade or area unions. Content analysis of answers to open-ended questions was performed by two independent coders. Results: Pharmacists have the best understanding about additional monitoring but at the same time do not recognize their role in enhancing monitoring. Only 40% of HCPs working with patients knows always or often if a specific medicine is additionally monitored. Half (53%) of HCPs do not tell or tell only rarely patients about additional monitoring. 18% of HCPs reported having received additional monitoring training whereas 29% had received general AE reporting training. AE reporting was more common among HCPs who had received training. Conclusions: Additional monitoring awareness among HCPs and patients should be increased by organizing regular educational events and making additional monitoring more visible. Educational events should emphasize the significance additional monitoring has on patient safety and promote a reporting culture among HCPs.

show abstract

Consumers’ knowledge and experiences of adverse drug reaction reporting in Australia: a national survey

Dedefo,

Lim,

Kassie

et al. 2024

Eur J Clin Pharmacol

View full text Add to dashboard Cite

This study aimed to investigate the current knowledge and experiences of consumers in Australia on adverse drug reaction (ADR) reporting and their reasons for reporting or not reporting ADRs, with a focus on the use of digital tools for ADR reporting. Methods A cross-sectional online survey was conducted among adults who had taken medicine in Australia. A structured questionnaire with multiple choice or Likert scale responses with an option for participants to provide free-text responses and pretested for face validity was used. Consumer characteristics, knowledge, and ADR reporting practices were analyzed using descriptive statistics and the chi-square test or Fisher’s exact test. Results A total of 544 survey responses were included in the analysis. The majority of respondents were women (68%), and 22% were aged between 65 and 74 years. Fifty-eight percent (n = 317) of respondents knew that they could report ADRs to either the Therapeutic Goods Administration (TGA), state or territory government health department, or healthcare professionals. Three-quarters (n = 405) of respondents stated that they had experienced an ADR; of these, 36% reported an ADR to either the TGA, state or territory government health department, or healthcare professionals. Among those who reported ADRs, 58% were unaware that they could use digital tools to report ADRs. The main reason for not reporting was that they did not think the ADR was serious enough to report (39%). Conclusion Over half of consumers knew that they could report ADR; however, improved consumer awareness about using digital tools for ADR reporting and increased ADR reporting is needed.

show abstract

What can we learn from the public’s understanding of drug information and safety? A population survey

Abstract: The public has great interest in useful information about all aspects involved in the use of medicines. This includes consumer reporting of suspected ADR, which is still unknown to many people.

Cited by 8 publications

References 28 publications

Public Awareness about Medicine Information, Safety, and Adverse Drug Reaction (ADR) Reporting in Dammam, Saudi Arabia

Public Awareness about Medicine Information, Safety, and Adverse Drug Reaction (ADR) Reporting in Dammam, Saudi Arabia

Regulation Awareness and Experience of Additional Monitoring among Healthcare Professionals in Finland

Consumers’ knowledge and experiences of adverse drug reaction reporting in Australia: a national survey

Contact Info

Product

Resources

About